{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:28:11Z","timestamp":1791145691170,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,11,29]],"date-time":"2009-11-29T00:00:00Z","timestamp":1259452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11914-009-0023-2","type":"journal-article","created":{"date-parts":[[2009,11,28]],"date-time":"2009-11-28T00:52:38Z","timestamp":1259369558000},"page":"134-139","source":"Crossref","is-referenced-by-count":205,"title":["Proinflammatory cytokines and osteoporosis"],"prefix":"10.1007","volume":"7","author":[{"given":"Robert R.","family":"McLean","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,29]]},"reference":[{"key":"23_CR1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S8756-3282(98)00077-5","volume":"23","author":"R.L. Jilka","year":"1998","unstructured":"Jilka RL: Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. Bone 1998, 23:75\u201381.","journal-title":"Bone"},{"key":"23_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","volume":"15","author":"L.C. Hofbauer","year":"2000","unstructured":"Hofbauer LC, Khosla S, Dunstan CR, et al.: The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000, 15:2\u201312.","journal-title":"J Bone Miner Res"},{"key":"23_CR3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0105-2896.2005.00334.x","volume":"208","author":"J.A. Clowes","year":"2005","unstructured":"Clowes JA, Riggs BL, Khosla S: The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev 2005, 208:207\u2013227.","journal-title":"Immunol Rev"},{"key":"23_CR4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"B.L. Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd: Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002, 23:279\u2013302.","journal-title":"Endocr Rev"},{"key":"23_CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","volume":"11","author":"R. Pacifici","year":"1996","unstructured":"Pacifici R: Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996, 11:1043\u20131051.","journal-title":"J Bone Miner Res"},{"key":"23_CR6","first-page":"115","volume":"21","author":"S.C. Manolagas","year":"2000","unstructured":"Manolagas SC: Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev 2000, 21:115\u2013137.","journal-title":"Endocr Rev"},{"key":"23_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/rp.57.1.385","volume":"57","author":"S.C. Manolagas","year":"2002","unstructured":"Manolagas SC, Kousteni S, Jilka RL: Sex steroids and bone. Recent Prog Horm Res 2002, 57:385\u2013409.","journal-title":"Recent Prog Horm Res"},{"key":"23_CR8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00223-002-1049-y","volume":"73","author":"S.R. Goldring","year":"2003","unstructured":"Goldring SR: Inflammatory mediators as essential elements in bone remodeling. Calcif Tissue Int 2003, 73:97\u2013100.","journal-title":"Calcif Tissue Int"},{"key":"23_CR9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rdc.2006.07.002","volume":"32","author":"L. Sinigaglia","year":"2006","unstructured":"Sinigaglia L, Varenna M, Girasole G, Bianchi G: Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin North Am 2006, 32:631\u2013658.","journal-title":"Rheum Dis Clin North Am"},{"key":"23_CR10","doi-asserted-by":"crossref","unstructured":"Haugeberg G, Conaghan PG, Quinn M, Emery P: Bone loss in active early rheumatoid arthritis patients treated with infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a twelve-month randomized, double blind, placebo-controlled study. Ann Rheum Dis 2009 Apr 21 (Epub ahead of print).","DOI":"10.1136\/ard.2008.106484"},{"key":"23_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/ard.2007.084426","volume":"68","author":"S. Visvanathan","year":"2009","unstructured":"Visvanathan S, van der Heijde D, Deodhar A, et al.: Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis. Ann Rheum Dis 2009, 68:175\u2013182.","journal-title":"Ann Rheum Dis"},{"key":"23_CR12","first-page":"855","volume":"35","author":"K. Briot","year":"2008","unstructured":"Briot K, Gossec L, Kolta S, et al.: Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment. J Rheumatol 2008, 35:855\u2013861.","journal-title":"J Rheumatol"},{"key":"23_CR13","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1196\/annals.1346.055","volume":"1068","author":"M. Pazianas","year":"2006","unstructured":"Pazianas M, Rhim AD, Weinberg AM, et al.: The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn\u2019s disease. Ann N Y Acad Sci 2006, 1068:543\u2013556.","journal-title":"Ann N Y Acad Sci"},{"key":"23_CR14","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1073\/pnas.84.13.4616","volume":"84","author":"R. Pacifici","year":"1987","unstructured":"Pacifici R, Rifas L, Teitelbaum S, et al.: Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A 1987, 84:4616\u20134620.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0378-5122(96)01080-8","volume":"26","author":"S.X. Zheng","year":"1997","unstructured":"Zheng SX, Vrindts Y, Lopez M, et al.: Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas 1997, 26:63\u201371.","journal-title":"Maturitas"},{"key":"23_CR16","first-page":"707","volume":"79","author":"S. Khosla","year":"1994","unstructured":"Khosla S, Peterson JM, Egan K, et al.: Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 1994, 79:707\u2013711.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0169-6009(91)90093-F","volume":"14","author":"M.T. Zarrabeitia","year":"1991","unstructured":"Zarrabeitia MT, Riancho JA, Amado JA, et al.: Cytokine production by peripheral blood cells in postmenopausal osteoporosis. Bone Miner 1991, 14:161\u2013167.","journal-title":"Bone Miner"},{"key":"23_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/jbmr.5650080108","volume":"8","author":"F.G. Hustmyer","year":"1993","unstructured":"Hustmyer FG, Walker E, Yu XP, et al.: Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Miner Res 1993, 8:51\u201359.","journal-title":"J Bone Miner Res"},{"key":"23_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF02247845","volume":"16","author":"N.G. Papadopoulos","year":"1997","unstructured":"Papadopoulos NG, Georganas K, Skoutellas V, et al.: Correlation of interleukin-6 serum levels with bone density in postmenopausal women. Clin Rheumatol 1997, 16:162\u2013165.","journal-title":"Clin Rheumatol"},{"key":"23_CR20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0531-5565(00)00220-5","volume":"36","author":"N. Giuliani","year":"2001","unstructured":"Giuliani N, Sansoni P, Girasole G, et al.: Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 2001, 36:547\u2013557.","journal-title":"Exp Gerontol"},{"key":"23_CR21","doi-asserted-by":"crossref","first-page":"11924","DOI":"10.1073\/pnas.90.24.11924","volume":"90","author":"T. Tamura","year":"1993","unstructured":"Tamura T, Udagawa N, Takahashi N, et al.: Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A 1993, 90:11924\u201311928.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1532-5415.1995.tb07328.x","volume":"43","author":"D.M. Kania","year":"1995","unstructured":"Kania DM, Binkley N, Checovich M, et al.: Elevated plasma levels of interleukin-6 in postmenopausal women do not correlate with bone density. J Am Geriatr Soc 1995, 43:236\u2013239.","journal-title":"J Am Geriatr Soc"},{"key":"23_CR23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jbmr.5650090821","volume":"9","author":"W.R. McKane","year":"1994","unstructured":"McKane WR, Khosla S, Peterson JM, et al.: Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Miner Res 1994, 9:1313\u20131318.","journal-title":"J Bone Miner Res"},{"key":"23_CR24","first-page":"2480","volume":"80","author":"A.K. Hogasen","year":"1995","unstructured":"Hogasen AK, Nordsletten L, Aasen AO, Falch JA: There is no difference in spontaneous and 17 beta-estradiol-induced interleukin-1 beta release by peripheral blood mononuclear cells from nonosteoporotic women with different rates of early postmenopausal bone loss. J Clin Endocrinol Metab 1995, 80:2480\u20132484.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR25","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","volume":"93","author":"C. Ding","year":"2008","unstructured":"Ding C, Parameswaran V, Udayan R, et al.: Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study. J Clin Endocrinol Metab 2008, 93:1952\u20131958.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s002239900559","volume":"63","author":"L.M. Salamone","year":"1998","unstructured":"Salamone LM, Whiteside T, Friberg D, et al.: Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women. Calcif Tissue Int 1998, 63:466\u2013470.","journal-title":"Calcif Tissue Int"},{"key":"23_CR27","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1359\/jbmr.2000.15.8.1545","volume":"15","author":"B. Abrahamsen","year":"2000","unstructured":"Abrahamsen B, Bonnevie-Nielsen V, Ebbesen EN, et al.: Cytokines and bone loss in a 5-year longitudinal study: hormone replacement therapy suppresses serum soluble interleukin-6 receptor and increases interleukin-1-receptor antagonist: the Danish Osteoporosis Prevention Study. J Bone Miner Res 2000, 15:1545\u20131554.","journal-title":"J Bone Miner Res"},{"key":"23_CR28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S8756-3282(96)00384-5","volume":"20","author":"B. Abrahamsen","year":"1997","unstructured":"Abrahamsen B, Bendtzen K, Beck-Nielsen H: Cytokines and T-lymphocyte subsets in healthy post-menopausal women: estrogen retards bone loss without affecting the release of IL-1 or IL-1ra. Bone 1997, 20:251\u2013258.","journal-title":"Bone"},{"key":"23_CR29","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.86.7.2398","volume":"86","author":"R. Pacifici","year":"1989","unstructured":"Pacifici R, Rifas L, McCracken R, et al.: Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 1989, 86:2398\u20132402.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"23_CR30","first-page":"1135","volume":"77","author":"R. Pacifici","year":"1993","unstructured":"Pacifici R, Vannice JL, Rifas L, Kimble RB: Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women: effects of menopause and estrogen\/progesterone therapy. J Clin Endocrinol Metab 1993, 77:1135\u20131141.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR31","first-page":"3351","volume":"80","author":"H. Bismar","year":"1995","unstructured":"Bismar H, Diel I, Ziegler R, Pfeilschifter J: Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 1995, 80:3351\u20133355.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR32","first-page":"2032","volume":"86","author":"C. Scheidt-Nave","year":"2001","unstructured":"Scheidt-Nave C, Bismar H, Leidig-Bruckner G, et al.: Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause. J Clin Endocrinol Metab 2001, 86:2032\u20132042.","journal-title":"J Clin Endocrinol Metab"},{"key":"23_CR33","first-page":"S79","volume":"23Suppl","author":"R.R. McLean","year":"2008","unstructured":"McLean RR, Roubenoff R, Hannan MT, et al.: Elevated production of interleukin 1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) by peripheral blood mononuclear cells (PBMC) is associated with increased hip fracture risk in elders: the Framingham Osteoporosis Study. J Bone Miner Res 2008, 23(Suppl):S79.","journal-title":"J Bone Miner Res"},{"key":"23_CR34","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1359\/jbmr.070409","volume":"22","author":"J.A. Cauley","year":"2007","unstructured":"Cauley JA, Danielson ME, Boudreau RM, et al.: Inflammatory markers and incident fracture risk in older men and women: the Health Aging and Body Composition Study. J Bone Miner Res 2007, 22:1088\u20131095.","journal-title":"J Bone Miner Res"},{"key":"23_CR35","first-page":"157","volume":"11","author":"D. Aderka","year":"1992","unstructured":"Aderka D, Engelmann H, Shemer-Avni Y, et al.: Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992, 11:157\u2013159.","journal-title":"Lymphokine Cytokine Res"},{"key":"23_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11914-006-0002-9","volume":"4","author":"M.L. Bouxsein","year":"2006","unstructured":"Bouxsein ML, Karasik D: Bone geometry and skeletal fragility. Curr Osteoporos Rep 2006, 4:49\u201356.","journal-title":"Curr Osteoporos Rep"},{"key":"23_CR37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.bone.2006.03.014","volume":"39","author":"F. Lauretani","year":"2006","unstructured":"Lauretani F, Bandinelli S, Russo CR, et al.: Correlates of bone quality in older persons. Bone 2006, 39:915\u2013921.","journal-title":"Bone"},{"key":"23_CR38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bone.2005.07.025","volume":"38","author":"C.R. Russo","year":"2006","unstructured":"Russo CR, Lauretani F, Seeman EB, et al.: Structural adaptations to bone loss in aging men and women. Bone 2006, 38:112\u2013118.","journal-title":"Bone"},{"key":"23_CR39","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI1368","volume":"101","author":"Z. Xing","year":"1998","unstructured":"Xing Z, Gauldie J, Cox G, et al.: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998, 101:311\u2013320.","journal-title":"J Clin Invest"},{"key":"23_CR40","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.180.4.1243","volume":"180","author":"E. Fattori","year":"1994","unstructured":"Fattori E, Cappelletti M, Costa P, et al.: Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994, 180:1243\u20131250.","journal-title":"J Exp Med"},{"key":"23_CR41","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","volume":"342","author":"P.M. Ridker","year":"2000","unstructured":"Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000, 342:836\u2013843.","journal-title":"N Engl J Med"},{"issue":"Pt2","key":"23_CR42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj3270425","volume":"327","author":"B. Weinhold","year":"1997","unstructured":"Weinhold B, Ruther U: Interleukin-6-dependent and -independent regulation of the human C-reactive protein gene. Biochem J 1997, 327(Pt 2):425\u2013429.","journal-title":"Biochem J"},{"key":"23_CR43","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U","volume":"181","author":"H. Moshage","year":"1997","unstructured":"Moshage H: Cytokines and the hepatic acute phase response. J Pathol 1997, 181:257\u2013266.","journal-title":"J Pathol"},{"key":"23_CR44","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00198-005-1840-5","volume":"16","author":"J.M. Koh","year":"2005","unstructured":"Koh JM, Khang YH, Jung CH, et al.: Higher circulating hsCRP levels are associated with lower bone mineral density in healthy pre- and postmenopausal women: evidence for a link between systemic inflammation and osteoporosis. Osteoporos Int 2005, 16:1263\u20131271.","journal-title":"Osteoporos Int"},{"key":"23_CR45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2265.2007.02853.x","volume":"67","author":"B.J. Kim","year":"2007","unstructured":"Kim BJ, Yu YM, Kim EN, et al.: Relationship between serum hsCRP concentration and biochemical bone turnover markers in healthy pre- and postmenopausal women. Clin Endocrinol (Oxf) 2007, 67:152\u2013158.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"23_CR46","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.296.11.1353","volume":"296","author":"J.A. Pasco","year":"2006","unstructured":"Pasco JA, Kotowicz MA, Henry MJ, et al.: High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA 2006, 296:1353\u20131355.","journal-title":"JAMA"},{"key":"23_CR47","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/archinte.166.22.2495","volume":"166","author":"G. Schett","year":"2006","unstructured":"Schett G, Kiechl S, Weger S, et al.: High-sensitivity Creactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med 2006, 166:2495\u20132501.","journal-title":"Arch Intern Med"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0023-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-009-0023-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0023-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:33:45Z","timestamp":1559421225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-009-0023-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,29]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1007\/s11914-009-0023-2","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,29]]}}}